Nasal spray shows promise for sudden vision loss in major trial
NCT ID NCT07453888
First seen Mar 07, 2026 · Last updated May 16, 2026 · Updated 8 times
Summary
This study tests a nasal spray called cenegermin (a lab-made nerve growth factor) to see if it can improve vision in people who recently lost sight due to a condition called NAION, which is like a stroke of the optic nerve. About 272 adults who had vision loss within the past two weeks will receive either the active spray or a placebo. The main goal is to see if more people gain at least 15 letters on an eye chart after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.